The present invention relates generally to balloon catheter devices used for imaging and treating tissue regions of interest. More particularly, the present invention relates generally to methods and devices for balloon catheters which can be used to image and treat tissue regions of interest, such as a vessel ostium, for various conditions, such as atrial fibrillation, etc.
An inflatable balloon catheter having an irrigation sheath may generally comprise two expandable membranes disposed about a catheter. The first inner membrane may be generally or substantially sealed to a catheter and may serve as a balloon to facilitate positioning of the device, e.g., within a lumen. This balloon structure when filled with fluid may expand and become engaged in direct contact with the tissue. A second (outer) membrane may be at least partially positioned over the balloon and may provide a pathway for delivery of fluid at the treatment site. In treating a tissue region with ablation energy, particularly within a body lumen such as a heart chamber, one device in particular may be used as shown and described in detail in U.S. Pat. No. 6,605,055, which is incorporated herein by reference in its entirety. As disclosed, an inflatable balloon which is sealed to a catheter may be advanced within a body lumen, such as within a chamber of a subject's heart, and inflated for contact against a tissue region to be treated.
A balloon catheter having a primary balloon member disposed about a catheter for inflation within the body, e.g., with the heart, may provide a transmission waveguide for radiation (such as laser radiation) projecting from an optical fiber to the ablation site, e.g., an ostium of a vessel. The catheter is typically an elongated hollow instrument having at least one lumen in communication with the port.
The outer membrane or sheath may define a distal opening to partially cover the primary balloon such that an irrigating fluid such as saline may be introduced through the annular conduit between the inner and outer membranes and exit through this opening to clear the region of blood between the balloon and the underlying tissue. In phototherapy applications, the removal of blood from the treatment site allows for the unobstructed and uniform delivery of ablative energy. In addition, the irrigating fluid cools the surface of the target site, thereby preventing overheating or burning of the tissue or coagulation. Also, it is noted that removal of blood allows direct visualization of the tissue surface with an appropriate imaging system.
An imager, e.g., CMOS or CCD electronic image sensor, may be affixed to an inside wall of the primary balloon with an electrical connection leading out of the distal end of the balloon to an image processing system for displaying the image, e.g., on a monitor. Direct visualization of the tissue surface is made possible when blood is flushed out and/or squeezed from the field of view. At least one light source, such as an LED, may also be affixed to an inside wall of the primary balloon coupled to an electrical connection as well. Both the light source and imager may be angled or positioned such that their field of view is directed towards the distal end of the balloon to capture and/or illuminate the underlying tissue region through the transparent balloon.
Another variation may include a fiberscope, which may be articulatable to control a direction of its distal end, positioned within the interior of the balloon. The distal end of the fiberscope may be articulated from outside the patient's body by the operator to direct an angle of the fiberscope within the balloon to view any region of contacted tissue through the balloon. The fiberscope may be optionally coupled to an imaging system, e.g., CMOS or CCD electronic image sensor, positioned external to the patient's body.
In yet another variation, an imager, such as an electronic imager, may be positioned upon the distal end of an articulatable member. The articulatable member may be manipulated from outside the patient's body to direct a viewing angle of the imager within the balloon. An imaging system may be located outside the patient's body for communicating with the imager for processing and/or displaying the images of the contacted tissue regions captured within the patient.
In yet another variation, fluid such as saline may be introduced through the conduit formed between the sheath and balloon. The introduced fluid, particularly an electrolytic fluid such as saline, may also be used to conduct ablative energy into the underlying tissue from the one or more electrodes which may be positioned along an outer surface of the balloon or sheath. The one or more electrodes may be positioned at locations where the fluid exits the conduit and contacts the underlying tissue such that the fluid flowing into contact with the electrodes may conduct any discharged energy, e.g., radio frequency (RF) energy, to ablate the tissue in combination with or exclusive of the ablative radiation energy projected from the optical fiber. The energy delivered via electrodes is not limited to RF energy may but also include any number of other ablative forms of energy such as cryo-ablation, microwave, ultrasonic, etc. Moreover, utilization of ablation energy in contact or in direct proximity to the tissue may provide additional ablative effects should blood obscure the radiation energy. Also, these electrodes may be also used independently from the laser ablation system or may be used to map electric potentials at the tissue surface.
Another variation of the balloon catheter may include one or more pores defined circumferentially about the distal end of the sheath such that the introduced fluid passing through the conduit may be diffused through the one or more pores into contact against the underlying tissue. The diffusion of the fluid through the pores may facilitate distribution of the ablation energy over the tissue.
In yet another variation, one or more ultrasound transducers may be positioned near or at a distal end of the balloon and/or sheath for placement in proximity to or in contact against the tissue region of interest. The one or more ultrasound transducers may be actuated to deliver ultrasonic signals into the underlying tissue to detect a thickness of the tissue, e.g., at the locations at which the radiative energy is to be applied. Knowledge of the thickness of the tissue to be ablated may help determine how much energy to provide or to determine, e.g., an appropriate amount of fluid flow needed to cool the tissue surface, etc., amongst other parameters. Tissue thickness detection utilizing ultrasound transducers is described in further detail in U.S. patent application Ser. No. 12/118,439 filed May 9, 2008 (U.S. Pat. Pub. 2009/0030412 A1), which is incorporated herein by reference in its entirety. Various methods may be utilized, e.g., by a controller such as a microprocessor in communication with the ultrasound transducers, for controlling and/or adjusting various parameters of an ablation procedure, e.g., power, laser intensity, flow rate, temperature, etc.
In treating a tissue region with ablation energy, particularly within a body lumen such as a heart chamber, various devices and methods may be utilized for visualizing and treating the tissue. One device is shown and described in detail in U.S. Pat. No. 6,605,055, which is incorporated herein by reference in its entirety. As disclosed, an inflatable balloon which is sealed to a catheter may be advanced within a body lumen, such as within a chamber of a subject's heart, and inflated for contact against a tissue region to be treated.
The outer membrane or sheath 16 may define a distal opening to partially cover the primary balloon 56, as shown, such that an irrigating fluid such as saline may be introduced through the annular conduit 20 between the inner and outer membranes and exit through this opening to clear the region of blood between the balloon and the underlying tissue. In phototherapy applications, the removal of blood from the treatment site allows for the unobstructed and uniform delivery of ablative energy 13. In addition, the irrigating fluid cools the surface of the target site, thereby preventing overheating or burning of the tissue or coagulation. Also, it is noted that removal of blood allows direct visualization of the tissue surface with an appropriate imaging system.
In this variation, an imager 32, e.g., CMOS or CCD electronic image sensor, may be affixed to an inside wall of the primary balloon 56 with an electrical connection 34 leading out of the distal end of the balloon to an image processing system for displaying the image, e.g., on a monitor. Direct visualization of the tissue surface is made possible when blood is flushed out and/or squeezed from the field of view. At least one light source 30, such as an LED, may also be affixed to an inside wall of primary balloon 56 coupled to an electrical connection 36 as well. Both light source 30 and imager 32 may be angled or positioned such that their field of view is directed towards the distal end of the balloon 56 to capture and/or illuminate the underlying tissue region 52 through the balloon 56 which may be optically transparent.
Another variation is illustrated in the cross-sectional side view of
In yet another variation,
In yet another variation,
Another variation of balloon catheter 50 is shown in the cross-sectional side view of
In yet another variation,
In the event that the detected thickness fails to meet the threshold level, the operator may be alerted (visual or auditory) of this anomaly 82 prompting the operator to re-measure 84 the tissue thickness. If the re-measured tissue thickness meets the threshold level, the ablation procedure may continue. Otherwise, the operator may manually determine the ablation parameters 86, e.g., lowering power levels, etc., and begin the ablation procedure 80. In the event that the re-measured tissue thickness meets the threshold level 76, the controller may automatically determine the appropriate ablation parameters 78, e.g., based upon a table of ablation parameters for a given thickness value, and the ablation procedure may begin 80.
The applications of the disclosed invention discussed above are not limited to certain treatments or regions of the body, but may include any number of other treatments and areas of the body. Modification of the above-described methods and devices for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of this disclosure. Moreover, various combinations of aspects between examples are also contemplated and are considered to be within the scope of this disclosure as well.
This application claims priority to U.S. Provisional App. 61/151,764 filed Feb. 11, 2009, which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
61151764 | Feb 2009 | US |